ADIPOQ and Cirrhosis: After NASH progression towards cirrhosis, circulating adiponectin seems to increase [305], probably due to two main mechanisms: a decrease in hepatic clearance of adiponectin and/or a compensatory mechanism aimed to buffer the hyper-secretion of inflammatory cytokines.